Coupons for Safe Water Project

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
AgeNot listed
SponsorUniversity of Chicago

About this trial

Guaranteeing access to safe drinking water is still a challenge in rural households in developing countries, and unsafe water sources are responsible for millions of deaths each year around the world. Coupons for free dilute chlorine solution are a cost-effective and effective way of ameliorating child health and reducing diarrhea incidence. It is still an empirical challenge, however, to see if the positive health effects will be maintained when the program is implemented at scale. In this study, investigators conduct a randomized controlled trial (RCT) at scale to study the impacts of a chlorine coupon program implemented at health clinics on child health, including self-reported diarrhea, fever, and cough incidence in the previous two weeks. Investigators further investigate the pathway of the impact, such as self-reported and objectively measured use of chlorine and frequency of visits to health clinics.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Currently pregnant women

Women living inside Health and Demographic Surveillance Systems (HDSS) catchment areas.

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Coupons for safe water program: Treatment

    Other intervention

    Randomly selected women in the treatment group will receive coupons for free chlorine solutions to be redeemed at the health facility each month.

  • Coupons for safe water program: Control

    Other intervention

    Randomly selected women in the treatment group will not receive coupons for free chlorine solutions after enrollment.

Treatment groups

3,468 Participants
are divided into 2 treatment groups
Group A: Treatment ArmExperimental treatment 1 intervention
Group B: Control ArmExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Verified chlorine usage - 6 months

Presence of free chlorine residual in the drinking water, as observed through water testing using chlorine test strips. Households with a non-zero concentration of residual chlorine are considered to have treated their water.

Time frame
The study will measure the presence of free chlorine residual in drinking water 6 months after the program launch.
2

Verified chlorine usage - 12 months

Presence of free chlorine residual in the drinking water, as observed through water testing using chlorine test strips. Households with a non-zero concentration of residual chlorine are considered to have treated their water.

Time frame
The study will measure the presence of free chlorine residual in drinking water 12 months after the program launch.
3

Verified chlorine usage - 18 months

Presence of free chlorine residual in the drinking water, as observed through water testing using chlorine test strips. Households with a non-zero concentration of residual chlorine are considered to have treated their water.

Time frame
The study will measure the presence of free chlorine residual in drinking water 18 months after the program launch.
4

Verified chlorine usage - 24 months

Presence of free chlorine residual in the drinking water, as observed through water testing using chlorine test strips. Households with a non-zero concentration of residual chlorine are considered to have treated their water.

Time frame
The study will measure the presence of free chlorine residual in drinking water 24 months after the program launch.

Secondary outcomes

1

Child morbidity - 6 months

Child morbidity will include caregiver-reported diarrhea, fever, and cough incidents and cost related to sickness in the previous two weeks. This study will be underpowered to detect impacts on mortality, but investigators will collect data on mortality in any case as this study will contribute to a meta-analysis conducted in the future.

Time frame
The study assesses child morbidity 6 months after the program launch.
2

Child morbidity - 12 months

Child morbidity will include caregiver-reported diarrhea, fever, and cough incidents and cost related to sickness in the previous two weeks. This study will be underpowered to detect impacts on mortality, but investigators will collect data on mortality in any case as this study will contribute to a meta-analysis conducted in the future.

Time frame
The study assesses child morbidity 12 months after the program launch.
3

Child morbidity - 18 months

Child morbidity will include caregiver-reported diarrhea, fever, and cough incidents and cost related to sickness in the previous two weeks. This study will be underpowered to detect impacts on mortality, but investigators will collect data on mortality in any case as this study will contribute to a meta-analysis conducted in the future.

Time frame
The study assesses child morbidity 18 months after the program launch.
4

Child morbidity - 24 months

Child morbidity will include caregiver-reported diarrhea, fever, and cough incidents and cost related to sickness in the previous two weeks. This study will be underpowered to detect impacts on mortality, but investigators will collect data on mortality in any case as this study will contribute to a meta-analysis conducted in the future.

Time frame
The study assesses child morbidity 24 months after the program launch.

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

University of Chicago

Lead sponsor

Abdul Latif Jameel Poverty Action Lab

Collaborator

Kenya Medical Research Institute

Collaborator